Bayer struggles to turn the page on glyphosate

The German group is dragging the takeover of Monsanto like a ball. He goes on the offensive in gene therapy and precision agriculture. The controversy around glyphosate is starting again. As the approval of this controversial substance expires in the European Union in December 2022, two reports with contradictory conclusions on its harmfulness have rekindled … Read more